Thursday August 31, 4:53 pm Eastern Time
Press Release
SOURCE: American Stock Exchange
Amex to Trade Options on Millennium
Pharmaceuticals, Inc.
NEW YORK, Aug. 31 /PRNewswire/ -- The American Stock Exchange will launch
trading in options on the Nasdaq National Market-listed stocks Millennium Pharmaceuticals, Inc. (Options Symbol: QMN
/ Stock Symbol: MLNM) on Tuesday, September 5, 2000.
Millennium Pharmaceuticals, Inc. options will open with position limits of 120,000 until November 20, 2000 that will be
reduced after that date to 75,000 contracts. The options trade on the February cycle. The specialist will be AGS Specialist
Partners.
Millennium Pharmaceuticals, Inc. is a drug discovery and development company. The Company incorporates large-scale
genetics, genomics, high throughput screening, and informatics in an integrated life science and technology platform.
The platform is applied in discovering and developing proprietary therapeutic and diagnostic human healthcare products
and services.
The American Stock Exchange®, a subsidiary of the National Association of Securities Dealers, Inc. (NASD®), is the
only primary exchange that offers trading across a full range of equities, Index Shares(SM), including structured
products, and options. In addition to its role as a national equities market, the Amex is the leader in Index Share listings
(DIAMONDS®, iShares(SM), MidCap SPDRs(TM), Nasdaq-100 Index Tracking Stock(SM), Select Sector SPDRs®, and
SPDRs®) and is the second-largest options exchange in the U.S., trading options on broad-based and sector indexes as
well as domestic and foreign stocks. For more information, visit amex.com. |
